Myelodysplastic syndromes, version 2.2017: Clinical practice guidelines in oncology Article Report uri icon

Overview

MeSH Major

  • Leukemia, Myeloid, Acute
  • Myelodysplastic Syndromes
  • Neoplasms, Second Primary

abstract

  • The myelodysplastic syndromes (MDS) comprise a heterogenous group of myeloid disorders with a highly variable disease course. Diagnostic criteria to better stratify patients with MDS continue to evolve, based on morphology, cytogenetics, and the presence of cytopenias. More accurate classification of patients will allow for better treatment guidance. Treatment encompasses supportive care, treatment of anemia, low-intensity therapy, and high-intensity therapy. This portion of the guidelines focuses on diagnostic classification, molecular abnormalities, therapeutic options, and recommended treatment approaches.

authors

publication date

  • January 2017

Research

keywords

  • Report

Identity

PubMed ID

  • 28040720

Additional Document Info

start page

  • 60

end page

  • 87

volume

  • 15

number

  • 1